tada, I do think good things are probably happening.

BETonMACE was a good but underpowered study. Had the futility analysis been done and if they would have been able raise financing to get the right statistical power we'd have a successful trial. Such is not the case. 

So here we are getting ready for the next trial or series of trials with breakthrough status.

The question is who is going to partner up with big $$$. The money will come. The issue is terms and conditions.

Thanks to everyone for your incredible posts and insights. I'm still really excited by the science. Apabetalone still seems to occupy a unique space.

GLTA

Toinv